Skip to Main content Skip to Navigation
Journal articles

Myofibrillar Myopathies: New Perspectives from Animal Models to Potential Therapeutic Approaches

Abstract : Myofibrillar myopathies (MFMs) are muscular disorders involving proteins that play a role in the structure, maintenance processes and protein quality control mechanisms closely related to the Z-disc in the muscular fibers. MFMs share common histological characteristics including progressive disorganization of the interfibrillar network and protein aggregation. Currently no treatment is available. In this review, we describe first clinical symptoms associated with mutations of the six genes (DES, CRYAB, MYOT, ZASP, FLNC and BAG3) primary involved in MFM and defining the origin of this pathology. As mechanisms determining the aetiology of the disease remain unclear yet, several research teams have developed animal models from invertebrates to mammalians species. Thus we describe here these different models that often recapitulate human clinical symptoms. Therefore they are very useful for deeper studies to understand early molecular and progressive mechanisms determining the pathology. Finally in the last part, we emphasize on the potential therapeutic approaches for MFM that could be conducted in the future. In conclusion, this review offers a link from patients to future therapy through the use of MFMs animal models.
Document type :
Journal articles
Complete list of metadata
Contributor : Colette ORANGE Connect in order to contact the contributor
Submitted on : Wednesday, January 13, 2021 - 9:42:33 AM
Last modification on : Monday, November 15, 2021 - 1:52:03 PM

Links full text




S Batonnet-Pichon, A Behin, E Cabet, F Delort, P Vicart, et al.. Myofibrillar Myopathies: New Perspectives from Animal Models to Potential Therapeutic Approaches. Journal of Neuromuscular Diseases, IOS Press, 2017, 4 (1), pp.1-15. ⟨10.3233/JND-160203⟩. ⟨hal-03108251⟩



Record views